Nature Biotechnology Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. It has an SJR impact factor of 22,781.

Nature Biotechnology focuses its scope in these topics and keywords: protein, antibody, control, gene, biotech, stem, virus, plant, transgenic, synthesis, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


Nature Biotechnology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

protein, antibody, control, gene, biotech, stem, virus, plant, transgenic, synthesis, coat, human, cell, tomato, tobacco, therapeutic, synthetic, scientific, research, reporting, recombinant, promise, phage, patent, neural, guanine, dna, chimeric,

Best articles by citations

On the road to therapeutic cloning

View more

Flies in the soup - European GM labeling legislation

View more

US to safeguard 'dual-use' biology research

View more

Protecting careers, not lives

View more

Encoding human serine phosphopeptides in bacteria for proteome-wide identification of phosphorylation-dependent interactions

View more

Author Correction: Template plasmid integration in germline genome-edited cattle

View more

Author Correction: Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds

View more

Cooperativity of Esterases and Xylanases in the Enzymatic Degradation of Acetyl Xylan

View more

The insects are coming

View more

Too little, too late: when is the right time for new leadership in biotech?

View more

To recruit the best R&D professionals, understand what drives them

View more

Erratum: Corrigendum: Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors

View more

d-(L-a-Aminoadipyl)-L-Cysteinyl-D-Valine Synthetase, the Multienzyme Integrating the Four Primary Reactions in beta-Lactam Biosynthesis, as a Model Peptide Synthetase

View more

Erratum: Corrigendum: Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

View more

Unshackling expression profiling arrays

View more

Human Proteinpedia enables sharing of human protein data

View more

Lessons from Eprex for biogeneric firms

View more

Either/or selection markers for plant transformation

View more

Genomics companies shop around for chemical expertise

View more

Journalism with a worldview

View more

McClellan moves on, sets sights on drug reimbursement

View more

Phage diabody repertoires for selection of large numbers of bispecific antibody fragments

View more

Rogan steps down as USPTO director

View more

Predicting antidepressant response by electroencephalography

View more